AQR Capital Management LLC Increases Stock Position in Encompass Health Co. (NYSE:EHC)

AQR Capital Management LLC lifted its position in Encompass Health Co. (NYSE:EHC - Free Report) by 136.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 689,206 shares of the company's stock after purchasing an additional 398,154 shares during the quarter. AQR Capital Management LLC owned 0.68% of Encompass Health worth $63,648,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB boosted its stake in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares in the last quarter. Transce3nd LLC bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC boosted its stake in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Tompkins Financial Corp purchased a new stake in Encompass Health during the fourth quarter valued at about $46,000. Finally, V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after buying an additional 177 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on EHC shares. Barclays boosted their target price on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. KeyCorp increased their price objective on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Truist Financial reissued a "buy" rating and set a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Finally, UBS Group boosted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research report on Monday, April 28th. One analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $120.86.

Encompass Health Trading Down 0.4 %

Shares of EHC traded down $0.52 during trading hours on Monday, reaching $116.12. 759,782 shares of the company traded hands, compared to its average volume of 685,605. Encompass Health Co. has a 12 month low of $82.74 and a 12 month high of $117.89. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company's fifty day moving average price is $101.73 and its two-hundred day moving average price is $99.26. The company has a market capitalization of $11.69 billion, a price-to-earnings ratio of 26.04, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business's revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.12 EPS. Equities research analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president now owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. This trade represents a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.